These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Molecular rigidity of ammonium compounds as a necessary condition for selective action on skeletal muscle cholinoreceptors]. Danilov AF; Starshinova LA; Fedorov DIu; Shelkovnikov SA Dokl Akad Nauk SSSR; 1981; 258(5):1238-42. PubMed ID: 6114826 [No Abstract] [Full Text] [Related]
6. [Dependence of curare-like activity of derivatives of cyclobutan dicarboxylic acids on the structure of the central part of the molecule]. Kharkevich DA Farmakol Toksikol; 1966; 29(6):715-20. PubMed ID: 6000368 [No Abstract] [Full Text] [Related]
7. The influence of the cis and trans configuration of certain stilbene-derived quaternary ammonium salts on blocking of neuromuscular transmission. Zaharia CN; Schell HD Rev Roum Physiol; 1972; 9(4):371-5. PubMed ID: 4666653 [No Abstract] [Full Text] [Related]
8. Pharmacological investigations of some bis-quaternary ammonium salts of N,N'-bis-(aminoacylo)piperazine derivatives. I. Relationship between structure and paralyzing action. Ciborska H Arch Int Pharmacodyn Ther; 1965 Apr; 154(2):382-94. PubMed ID: 5838343 [No Abstract] [Full Text] [Related]
9. [Pharmacologic study of quaternary bis-phosphoramide and bis-ammonium compounds. I. Neuromuscular action]. Cheymol G; Olive G Ann Pharm Fr; 1969 Feb; 27(2):89-95. PubMed ID: 5399810 [No Abstract] [Full Text] [Related]
10. [Blocking effects of cycleanine dimethobromide on nerve ganglia and neuromuscular junctions (author's transl)]. Lu YQ; Xu DZ; Mao YK; Wei X; Yang ZC Zhongguo Yao Li Xue Bao; 1981 Dec; 2(4):223-6. PubMed ID: 6462019 [No Abstract] [Full Text] [Related]
11. The pharmacology of new short-acting nondepolarizing ester neuromuscular blocking agents: clinical implications. Savarese JJ; Ginsburg S; Lee SM; Kitz RJ Anesth Analg; 1973; 52(6):982-8. PubMed ID: 4271295 [No Abstract] [Full Text] [Related]
12. [Acetylenic phenolic bis-ethers with curarizing properties. I. Triethylammonium iodide series]. Goyer GR; Salvador RL; Bolduc R Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):18-30. PubMed ID: 5646014 [No Abstract] [Full Text] [Related]
13. Synthesis and effect of asymmetric 1,4-bis(aminoacyl) piperazines on neuromuscular transmission. Groszkowski S; Korzycka L; Szadowska A; KamiĆska A; Winer A Pol J Pharmacol Pharm; 1982; 34(5-6):383-9. PubMed ID: 6314300 [TBL] [Abstract][Full Text] [Related]
14. [Causes for species difference in acute toxicity of chlorocholine chloride]. Hennighausen G; Tiefenbach B Arch Exp Veterinarmed; 1977; 31(4):527-32. PubMed ID: 203241 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the neuromuscular blocking property of isococculidine. Kar K; Mukherjee KC; Dhawan BN Indian J Exp Biol; 1977 Jul; 15(7):547-51. PubMed ID: 598896 [No Abstract] [Full Text] [Related]
16. The potentiation of the neuromuscular blocking activity of hexafluorenium and d-tubocurarine by volatile anaesthetics. Vermeer GA; Hess SW Anaesthesist; 1974 Feb; 23(2):72-8. PubMed ID: 4458482 [No Abstract] [Full Text] [Related]
17. Structure-activity relationships of N-alkyl and heterocyclic analogs of hemicholinium-3. Benz FW; Long JP J Pharmacol Exp Ther; 1969 Aug; 168(2):315-21. PubMed ID: 5803315 [No Abstract] [Full Text] [Related]
18. Cardiovascular and neuromuscular effects of pancuronium bromide in the pony. Manley SV; Steffey EP; Howitt GA; Woliner M Am J Vet Res; 1983 Jul; 44(7):1349-53. PubMed ID: 6881672 [No Abstract] [Full Text] [Related]
19. The rate of action of competitive neuromuscular blocking agents. Waud DR J Pharmacol Exp Ther; 1967 Oct; 158(1):99-114. PubMed ID: 6054082 [No Abstract] [Full Text] [Related]